Goldman found the rare companies this year that could actually grow sales and earnings

Logo of global biopharmaceutical company Bristol-Myers Squibb is pictured on the blouse of an employee in Le Passage, near Agen, France March 29, 2018.
Regis Duvignau | REUTERS

(This story is for CNBC Pro subscribers only.)

Earnings and sales growth are going to be hard to come by this year thanks to the coronavirus shutdown.

As U.S. businesses grapple with the economic downturn, Goldman Sachs made a list for clients of the stocks in the S&P 500 that it believes will generate the most earnings growth and revenue growth in 2020.